HIV Alert: Novel Strategies and Agents for HIV Management

In this downloadable slideset, Daniel R. Kuritzkes, MD, and Paul E. Sax, MD, review potential future HIV treatment strategies—including long-acting ART, dual-therapy regimens, and investigational agents—and discuss where these strategies might fit into the current therapeutic landscape.
Format: Microsoft PowerPoint (.ppt)
File Size: 926 KB
Released: June 21, 2016


Supported by independent educational grants from
Gilead Sciences
ViiV Healthcare

Related Content

Downloadable slides of key HIV studies presented at IDWeek, HIV Comorbidities Workshop, and HIV Glasgow 2018, reported by Clinical Care Options

Peter Reiss, MD, PhD Babafemi Taiwo, MBBS Released: November 14, 2018

LATTE-2 Week 160 data on long-acting injectable CAB + RPV for maintenance ART presented at HIV Glasgow 2018, reported by Clinical Care Options

Released: November 13, 2018

Released: November 13, 2018

Expert audio analysis by David A. Wohl, MD, of key HIV studies presented at IDWeek 2018 and HIV Glasgow 2018 as reported by Clinical Care Options

David A. Wohl, MD Released: November 12, 2018

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.


More info

CCO’s educational programs are available completely free of charge on the,, and Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?